What is Phelan-McDermid Syndrome? What are its symptoms? How many people are affected? These are questions that caregivers of individuals with Phelan-McDermid Syndrome hear all of the time.

Caregiver — share this infographic with friends to help them learn more about PMS!

13 views1 comment

What an onerous year it has been for so many of us, especially for families who have children with neurodevelopmental disabilities. The difficulties we have witnessed in our own children this year only underscore the need for effective treatments for Phelan-McDermid Syndrome.

That’s why we’re excited to announce the launch of CureSHANK’s two signature programs to address the major gap areas in drug development for Phelan-McDermid Syndrome: SHANK3 Therapeutic Accelerator and Trial Ready.

As co-founders of CureSHANK, we are working with the greatest sense of urgency to develop effective treatments not just for future generations of children with Phelan-McDermid Syndrome, but for our own children.

Please show your support by making a donation to CureSHANK:

Thank you and happy holidays! Geraldine, Paulina & Abby

9 views0 comments

We are proud to be participating in Healx's webinar on the development of in vitro models for rare disease research on August 13. CureSHANK President and Co-Founder Geraldine Bliss, whose son Charles has Phelan-McDermid Syndrome, will discuss initiating collaborations for modeling diseases .

In vitro modeling is the first step in developing therapies for rare diseases like PMS. This step of the research process is conducted via test tubes or cell culture. After therapies are found successful in vitro, they are tested on animals, and then finally on humans in clinical trials.

4 views0 comments